CXCL12 G801A polymorphism is a risk factor forSporadic prostate cancer susceptiblifity

被引:75
作者
Hirata, Hiroshi
Hinoda, Yuji
Kikuno, Nobuyuki
Kawamoto, Ken
Dahiya, Angela V.
Suehiro, Yutaka
Tanaka, Yuichiro
Dahiya, Rajvir
机构
[1] Vet Affairs Med Ctr, Urol Res Ctr 112F, Dept Urol, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, San Francisco, CA 94121 USA
[3] Yamaguchi Univ, Grad Sch Med, Dept Lab Med, Yamaguchi, Japan
关键词
FACTOR-I; CELL-MIGRATION; SDF-1; GENE; EXPRESSION; P53; SUSCEPTIBILITY; CXCR4; METASTASIS; VARIANTS; CODON-72;
D O I
10.1158/1078-0432.CCR-07-0859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis. A single nucleoticle polymorphism of CXCL12 G801A has been described and is regarded as a target for cis-acting factor that has the ability to up-regulate CXCL12 expression. Currently, there are no reports investigating the role of CXCL 12 G801A polymorphism in prostate cancer (PC). Experimental Design: We genotyped CXCL12 G801A and p53Arg72Pro in 167 PC patients and 167 age-matched healthy subjects. Genotyping was done with PCR-RFLP and confirmed by direct DNA sequencing. To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues. Results: A significant increase in the GA + AA genotype of the CXCL12 G801A polymorphism was observed in PC patients compared with healthy controls. The frequency of CXCL12 AA genotype was significantly higher in a group of patients with lymph node metastasis (23%) compared with those without metastasis (7%). The frequency of CXCL12 expression in AA + GA genotype carriers was significantly higher than that in GG genotype carriers. Among the carriers with CXCL12 GA + AA genotypes, CXCR4 expression was also significantly higher compared with those with the GG genotype. Moreover, among the groups with both CXCL12-and CXCR4-positive staining, the frequency of the CXCL12 GA + AA genotype was high. Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72ArglPro + Pro/Pro genotype on the frequency of PC. These results indicate that the p53 codon 72 polymorphism may interact with CXCL12 G801A. Conclusions: This is the first report showing that CXCL12 G801A polymorphism may be a risk factor for PC. Moreover, this study suggests that this polymorphism can be an important marker for detecting microinvasion and PC metastasis.
引用
收藏
页码:5056 / 5062
页数:7
相关论文
共 31 条
[1]   CODON-72 POLYMORPHISM OF THE TP53 GENE [J].
ARA, S ;
LEE, PSY ;
HANSEN, MF ;
SAYA, H .
NUCLEIC ACIDS RESEARCH, 1990, 18 (16) :4961-4961
[2]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[3]   Association of breast cancer outcome with status of p53 and MDM2 SNP309 [J].
Boersma, Brenda J. ;
Howe, Tiffany M. ;
Goodman, Julie E. ;
Yfantis, Harry G. ;
Lee, Dong H. ;
Chanock, Stephen J. ;
Ambs, Stefan .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (13) :911-919
[4]   Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States) [J].
Chan, JM ;
Holick, CN ;
Leitzmann, MF ;
Rimm, EB ;
Willett, WC ;
Stampfer, MJ ;
Giovannucci, EL .
CANCER CAUSES & CONTROL, 2006, 17 (02) :199-208
[5]  
Cheng L, 2001, CANCER-AM CANCER SOC, V91, P66, DOI 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO
[6]  
2-P
[7]   CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12 [J].
Chinni, SR ;
Sivalogan, S ;
Dong, Z ;
Trindade, JC ;
Deng, XY ;
Bonfil, RD ;
Cher, ML .
PROSTATE, 2006, 66 (01) :32-48
[8]   Stromal factors involved in prostate carcinoma metastasis to bone [J].
Cooper, CR ;
Chay, CH ;
Gendernalik, JD ;
Lee, HL ;
Bhatia, J ;
Taichman, RS ;
McCauley, LK ;
Keller, ET ;
Pienta, KJ .
CANCER, 2003, 97 (03) :739-747
[9]   Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis [J].
Darash-Yahana, M ;
Pikarsky, E ;
Abramovitch, R ;
Zeira, E ;
Pal, B ;
Karplus, R ;
Beider, K ;
Avniel, S ;
Kasem, S ;
Galun, E ;
Peled, A .
FASEB JOURNAL, 2004, 18 (09) :1240-+
[10]  
Dimberg J, 2007, INT J MOL MED, V19, P11